{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:42:06Z","timestamp":1788320526931,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2019R1C1C1009617"],"award-info":[{"award-number":["NRF-2019R1C1C1009617"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bbrc.2023.10.008","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:23:57Z","timestamp":1696393437000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells"],"prefix":"10.1016","volume":"682","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5102-8885","authenticated-orcid":false,"given":"Yeon-Jee","family":"Kahm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-4449","authenticated-orcid":false,"given":"Rae-Kwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.10.008_bib1","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bbrc.2023.10.008_bib2","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2014.10.FOCUS12367","article-title":"Survival and low-grade glioma: the emergence of genetic information","volume":"38","author":"Claus","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.bbrc.2023.10.008_bib3","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.3390\/ijms21186957","article-title":"HSPA1L enhances cancer stem cell-like properties by activating IGF1R\u03b2 and regulating \u03b2-catenin transcription","volume":"21","author":"Choi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.10.008_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1073\/pnas.1018696108","article-title":"A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations","volume":"108","author":"Yan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2023.10.008_bib5","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1158\/0008-5472.CAN-04-1918","article-title":"Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice","volume":"64","author":"Schimmer","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2023.10.008_bib6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41598-020-79736-7","article-title":"BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration","volume":"11","author":"Xu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2023.10.008_bib7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.21037\/atm-22-3496","article-title":"Bioinformatics analysis of BIRC5 in human cancers","volume":"10","author":"Ye","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbrc.2023.10.008_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s12276-020-0397-x","article-title":"Therapeutics targeting the fibrinolytic system","volume":"52","author":"Lin","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2023.10.008_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/562481","article-title":"PAI-1: an integrator of cell signaling and migration","author":"Czekay","year":"2011","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.bbrc.2023.10.008_bib10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0026-0495(93)90005-9","article-title":"The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance","volume":"42","author":"Potter van Loon","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2023.10.008_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41419-018-0808-2","article-title":"Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance","volume":"9","author":"Che","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2023.10.008_bib12","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.3390\/ijms24076855","article-title":"RanBP1: a potential therapeutic target for cancer stem cells in lung cancer and glioma","volume":"24","author":"Kahm","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.10.008_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-230X-11-71","article-title":"Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines","volume":"11","author":"Cao","year":"2011","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbrc.2023.10.008_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semcancer.2012.04.001","article-title":"Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links","volume":"22","author":"Scheel","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2023.10.008_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036905","article-title":"Cancer stem cells and epithelial-to-mesenchymal transition in cancer metastasis","volume":"10","author":"Celi\u00e0-Terrassa","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.bbrc.2023.10.008_bib16","first-page":"2973","article-title":"Links between cancer stem cells and epithelial\u2013mesenchymal transition","volume":"8","author":"Wang","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrc.2023.10.008_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5487\/TR.2010.26.4.245","article-title":"Epithelial-mesenchymal transition and cell invasion","volume":"26","author":"Son","year":"2010","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.bbrc.2023.10.008_bib18","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/s41467-019-10269-y","article-title":"Collective cell migration and metastases induced by an epithelial-to-mesenchymal transition in Drosophila intestinal tumors","volume":"10","author":"Campbell","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2023.10.008_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12964-021-00713-2","article-title":"The epithelial-mesenchymal transition and the cytoskeleton in bioengineered systems","volume":"19","author":"Leggett","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2023.10.008_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1158\/0008-5472.CAN-11-3070","article-title":"Cancer stem cells: distinct entities or dynamically regulated phenotypes?","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2023.10.008_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5619472","article-title":"Stemness in cancer: stem cells, cancer stem cells, and Their microenvironment","author":"Aponte","year":"2017","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.bbrc.2023.10.008_bib22","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.18632\/oncotarget.6805","article-title":"Notch and Wnt\/\u03b2-catenin signaling pathway play important roles in activating liver cancer stem cells","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2023.10.008_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","article-title":"Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways","volume":"8","author":"Takebe","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2023.10.008_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2023.10.008_bib25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1523-1755.2005.00491.x","article-title":"MAPK\/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells","volume":"68","author":"Guo","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrc.2023.10.008_bib26","doi-asserted-by":"crossref","first-page":"H1937","DOI":"10.1152\/ajpheart.00868.2006","article-title":"Phosphatidylinositol 3-kinase\/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells","volume":"292","author":"Mukai","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23011464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23011464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:11:01Z","timestamp":1781701861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23011464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"alternative-id":["S0006291X23011464"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.10.008","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}